DSF, a well-known aldehyde dehydrogenase (ALDH) inhibitor, has demonstrated significant anti-cancer properties, particularly against ALDH-positive breast cancer stem cells (Ni Y. L. et al., 2022). This evidence concerns the gene LDHA and breast cancer.